
Johnson & Johnson
JNJHealthcare|Drug Manufacturers - General|US
$276.22
+3.90 (+1.43%)
DCF Value
$295.64
Graham Number
$70.20
Cash / Share
$7.04
Ownership Breakdown
99.9%
Float
2407.3M
Shares Outstanding
2404.4M
Float Shares
Major Holders (1)
Combined: 7.5%
Holders of 5%+ from their latest Schedule 13D/13G filing in the last two years. Percentages are as of each filing date.
| Holder | Type | % of Class | Shares | Filed | Filing |
|---|---|---|---|---|---|
| Vanguard Capital Management | Investment adviser | 7.49% | 180,631,228 | May 1, 2026 | 13D/G |
Insider Trades (100)
Last 4 quarters: 1,436,131.828 acquired · 1,523,818 disposed
| Insider | Position | Date | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Pinto Daniel E | director | Sep 8, 2026 | AWARD | 113.098 | — | — | Form 4 |
| Woods Eugene A. | director | Sep 8, 2026 | AWARD | 135.717 | — | — | Form 4 |
| HEWSON MARILLYN A | director | Sep 8, 2026 | AWARD | 180.956 | — | — | Form 4 |
| Schmid Timothy | EVP, WW Chair, MedTech | Sep 2, 2026 | OPTION EX. | 22,527 | $151.41 | $3.4M | Form 4 |
| Schmid Timothy | EVP, WW Chair, MedTech | Sep 2, 2026 | OPTION EX. | 11,070 | $131.94 | $1.5M | Form 4 |
| Schmid Timothy | EVP, WW Chair, MedTech | Sep 2, 2026 | SELL | 22,527 | $274.74 | $6.2M | Form 4 |
| Schmid Timothy | EVP, WW Chair, MedTech | Sep 2, 2026 | OPTION EX. | 11,070 | $131.94 | $1.5M | Form 4 |
| Schmid Timothy | EVP, WW Chair, MedTech | Sep 2, 2026 | OPTION EX. | 22,527 | $151.41 | $3.4M | Form 4 |
| Cavanaugh Thomas | EVP WW Chair, Innovative Med. | Sep 1, 2026 | OTHER | 0 | — | — | Form 4 |
| Cavanaugh Thomas | EVP WW Chair, Innovative Med. | Sep 1, 2026 | OTHER | 0 | — | — | Form 4 |
| Cavanaugh Thomas | EVP WW Chair, Innovative Med. | Sep 1, 2026 | OTHER | 15,839 | $243.45 | $3.9M | Form 4 |
| Cavanaugh Thomas | EVP WW Chair, Innovative Med. | Sep 1, 2026 | OTHER | 25,493 | $156.15 | $4.0M | Form 4 |
| Cavanaugh Thomas | EVP WW Chair, Innovative Med. | Sep 1, 2026 | OTHER | 23,311 | $157.92 | $3.7M | Form 4 |
| Cavanaugh Thomas | EVP WW Chair, Innovative Med. | Sep 1, 2026 | OTHER | 15,081 | $162.75 | $2.5M | Form 4 |
| Cavanaugh Thomas | EVP WW Chair, Innovative Med. | Feb 14, 2025 | OTHER | 11,906 | $165.89 | $2.0M | Form 4 |
| Cavanaugh Thomas | EVP WW Chair, Innovative Med. | Feb 8, 2024 | OTHER | 14,383 | $164.62 | $2.4M | Form 4 |
| Cavanaugh Thomas | EVP WW Chair, Innovative Med. | Feb 10, 2023 | OTHER | 16,543 | $151.41 | $2.5M | Form 4 |
| Cavanaugh Thomas | EVP WW Chair, Innovative Med. | Sep 1, 2026 | OTHER | 965 | — | — | Form 4 |
| Taubert Jennifer L | EVP, WWC. Innovative Medicine | Aug 17, 2026 | OPTION EX. | 15,000 | $115.67 | $1.7M | Form 4 |
| Taubert Jennifer L | EVP, WWC. Innovative Medicine | Aug 17, 2026 | SELL | 15,000 | $263.36 | $4.0M | Form 4 |
| Taubert Jennifer L | EVP, WWC. Innovative Medicine | Aug 17, 2026 | OPTION EX. | 15,000 | $115.67 | $1.7M | Form 4 |
| Duato Joaquin | director, officer: CEO and Chairman of the Board | Aug 13, 2026 | OPTION EX. | 123,291 | $115.67 | $14.3M | Form 4 |
| Duato Joaquin | director, officer: CEO and Chairman of the Board | Aug 13, 2026 | SELL | 20,976 | $262.00 | $5.5M | Form 4 |
| Duato Joaquin | director, officer: CEO and Chairman of the Board | Aug 13, 2026 | SELL | 102,315 | $261.00 | $26.7M | Form 4 |
| Duato Joaquin | director, officer: CEO and Chairman of the Board | Aug 13, 2026 | OPTION EX. | 123,291 | $115.67 | $14.3M | Form 4 |
| Duato Joaquin | director, officer: CEO and Chairman of the Board | Aug 5, 2026 | SELL | 41,957 | $258.06 | $10.8M | Form 4 |
| Duato Joaquin | director, officer: CEO and Chairman of the Board | Aug 5, 2026 | SELL | 6,523 | $258.74 | $1.7M | Form 4 |
| Forminard Elizabeth | EVP, Chief Legal Officer | Aug 6, 2026 | OPTION EX. | 9,344 | $131.94 | $1.2M | Form 4 |
| Forminard Elizabeth | EVP, Chief Legal Officer | Aug 6, 2026 | SELL | 9,344 | $257.75 | $2.4M | Form 4 |
| Forminard Elizabeth | EVP, Chief Legal Officer | Aug 6, 2026 | SELL | 6,574 | $255.93 | $1.7M | Form 4 |
| Forminard Elizabeth | EVP, Chief Legal Officer | Aug 6, 2026 | OPTION EX. | 9,344 | $131.94 | $1.2M | Form 4 |
| Broadhurst Vanessa | EVP, Global Corp Affairs | Jul 20, 2026 | OPTION EX. | 11,925 | $131.94 | $1.6M | Form 4 |
| Broadhurst Vanessa | EVP, Global Corp Affairs | Jul 20, 2026 | OPTION EX. | 11,129 | $129.51 | $1.4M | Form 4 |
| Broadhurst Vanessa | EVP, Global Corp Affairs | Jul 20, 2026 | SELL | 23,054 | $251.27 | $5.8M | Form 4 |
| Broadhurst Vanessa | EVP, Global Corp Affairs | Jul 20, 2026 | OPTION EX. | 11,129 | $129.51 | $1.4M | Form 4 |
| Broadhurst Vanessa | EVP, Global Corp Affairs | Jul 20, 2026 | OPTION EX. | 11,925 | $131.94 | $1.6M | Form 4 |
| Wengel Kathryn E | EVP, Chief TO and Risk Officer | Jun 11, 2026 | OPTION EX. | 10,000 | $115.67 | $1.2M | Form 4 |
| Wengel Kathryn E | EVP, Chief TO and Risk Officer | Jun 11, 2026 | SELL | 10,000 | $241.15 | $2.4M | Form 4 |
| Wengel Kathryn E | EVP, Chief TO and Risk Officer | Jun 11, 2026 | OPTION EX. | 10,000 | $115.67 | $1.2M | Form 4 |
| Woods Eugene A. | director | Jun 9, 2026 | AWARD | 161.089 | — | — | Form 4 |
| Pinto Daniel E | director | Jun 9, 2026 | AWARD | 134.241 | — | — | Form 4 |
| HEWSON MARILLYN A | director | Jun 9, 2026 | AWARD | 214.786 | — | — | Form 4 |
| REED JOHN C | EVP, Innovative Medicine, R&D | May 1, 2026 | OPTION EX. | 25,255 | — | — | Form 4 |
| REED JOHN C | EVP, Innovative Medicine, R&D | May 1, 2026 | TAX W/H | 11,002 | $229.85 | $2.5M | Form 4 |
| REED JOHN C | EVP, Innovative Medicine, R&D | May 1, 2026 | OPTION EX. | 25,255 | — | — | Form 4 |
| Woods Eugene A. | director | Apr 23, 2026 | AWARD | 975 | — | — | Form 4 |
| West Nadja | director | Apr 23, 2026 | AWARD | 975 | — | — | Form 4 |
| WEINBERGER MARK A | director | Apr 23, 2026 | AWARD | 975 | — | — | Form 4 |
| Pinto Daniel E | director | Apr 23, 2026 | AWARD | 1,712 | — | — | Form 4 |
| MORIKIS JOHN G | director | Apr 23, 2026 | AWARD | 1,540 | — | — | Form 4 |
| McClellan Mark B. | director | Apr 23, 2026 | AWARD | 975 | — | — | Form 4 |
| Joly Hubert | director | Apr 23, 2026 | AWARD | 975 | — | — | Form 4 |
| Johnson Paula A | director | Apr 23, 2026 | AWARD | 975 | — | — | Form 4 |
| HEWSON MARILLYN A | director | Apr 23, 2026 | AWARD | 975 | — | — | Form 4 |
| Doudna Jennifer A | director | Apr 23, 2026 | AWARD | 975 | — | — | Form 4 |
| Beckerle Mary C | director | Apr 23, 2026 | AWARD | 975 | — | — | Form 4 |
| HEWSON MARILLYN A | director | Mar 10, 2026 | AWARD | 206.492 | — | — | Form 4 |
| HEWSON MARILLYN A | director | Mar 4, 2025 | AWARD | 75.256 | — | — | Form 4 |
| Pinto Daniel E | director | Mar 10, 2026 | AWARD | 129.058 | — | — | Form 4 |
| Woods Eugene A. | director | Mar 10, 2026 | AWARD | 154.869 | — | — | Form 4 |
| Decker Robert J | VP Corporate Controller | Feb 27, 2026 | OPTION EX. | 4,075 | $115.67 | $471.4K | Form 4 |
| Decker Robert J | VP Corporate Controller | Feb 27, 2026 | SELL | 4,075 | $247.87 | $1.0M | Form 4 |
| Decker Robert J | VP Corporate Controller | Feb 27, 2026 | OPTION EX. | 4,075 | $115.67 | $471.4K | Form 4 |
| Schmid Timothy | EVP, WW Chair, MedTech | Feb 20, 2026 | SELL | 1,322 | $245.66 | $324.8K | Form 4 |
| Swanson James D. | EVP, CIO | Feb 13, 2026 | OPTION EX. | 22,191 | $162.75 | $3.6M | Form 4 |
| Swanson James D. | EVP, CIO | Feb 17, 2026 | OPTION EX. | 20,521 | $164.62 | $3.4M | Form 4 |
| Swanson James D. | EVP, CIO | Feb 13, 2026 | OPTION EX. | 19,368 | $165.89 | $3.2M | Form 4 |
| Swanson James D. | EVP, CIO | Feb 13, 2026 | OPTION EX. | 9,412 | — | — | Form 4 |
| Swanson James D. | EVP, CIO | Feb 15, 2026 | OPTION EX. | 709 | — | — | Form 4 |
| Swanson James D. | EVP, CIO | Feb 17, 2026 | SELL | 20,521 | $242.70 | $5.0M | Form 4 |
| Swanson James D. | EVP, CIO | Feb 15, 2026 | TAX W/H | 309 | $243.45 | $75.2K | Form 4 |
| Swanson James D. | EVP, CIO | Feb 15, 2026 | OPTION EX. | 492 | — | — | Form 4 |
| Swanson James D. | EVP, CIO | Feb 15, 2026 | TAX W/H | 214 | $243.45 | $52.1K | Form 4 |
| Swanson James D. | EVP, CIO | Feb 13, 2026 | SELL | 22,191 | $243.71 | $5.4M | Form 4 |
| Swanson James D. | EVP, CIO | Feb 13, 2026 | SELL | 19,368 | $243.76 | $4.7M | Form 4 |
| Swanson James D. | EVP, CIO | Feb 13, 2026 | TAX W/H | 3,547 | $244.55 | $867.4K | Form 4 |
| Swanson James D. | EVP, CIO | Feb 15, 2026 | AWARD | 19,449 | $243.45 | $4.7M | Form 4 |
| Swanson James D. | EVP, CIO | Feb 13, 2026 | OPTION EX. | 447 | — | — | Form 4 |
| Swanson James D. | EVP, CIO | Feb 13, 2026 | TAX W/H | 143 | $244.55 | $35.0K | Form 4 |
| Swanson James D. | EVP, CIO | Feb 15, 2026 | OPTION EX. | 709 | — | — | Form 4 |
| Swanson James D. | EVP, CIO | Feb 15, 2026 | AWARD | 1,397 | — | — | Form 4 |
| Swanson James D. | EVP, CIO | Feb 15, 2026 | OPTION EX. | 492 | — | — | Form 4 |
| Swanson James D. | EVP, CIO | Feb 13, 2026 | OPTION EX. | 9,412 | — | — | Form 4 |
| Swanson James D. | EVP, CIO | Feb 17, 2026 | OPTION EX. | 20,521 | $164.62 | $3.4M | Form 4 |
| Swanson James D. | EVP, CIO | Feb 13, 2026 | OPTION EX. | 22,191 | $162.75 | $3.6M | Form 4 |
| Swanson James D. | EVP, CIO | Feb 13, 2026 | OPTION EX. | 447 | — | — | Form 4 |
| Swanson James D. | EVP, CIO | Feb 13, 2026 | OPTION EX. | 19,368 | $165.89 | $3.2M | Form 4 |
| Wengel Kathryn E | EVP, Chief TO and Risk Officer | Feb 13, 2026 | OPTION EX. | 13,706 | — | — | Form 4 |
| Wengel Kathryn E | EVP, Chief TO and Risk Officer | Feb 15, 2026 | OPTION EX. | 635 | — | — | Form 4 |
| Wengel Kathryn E | EVP, Chief TO and Risk Officer | Feb 15, 2026 | TAX W/H | 325 | $243.45 | $79.1K | Form 4 |
| Wengel Kathryn E | EVP, Chief TO and Risk Officer | Feb 15, 2026 | OPTION EX. | 606 | — | — | Form 4 |
| Wengel Kathryn E | EVP, Chief TO and Risk Officer | Feb 15, 2026 | TAX W/H | 310 | $243.45 | $75.5K | Form 4 |
| Wengel Kathryn E | EVP, Chief TO and Risk Officer | Feb 13, 2026 | TAX W/H | 6,414 | $244.55 | $1.6M | Form 4 |
| Wengel Kathryn E | EVP, Chief TO and Risk Officer | Feb 13, 2026 | OPTION EX. | 651 | — | — | Form 4 |
| Wengel Kathryn E | EVP, Chief TO and Risk Officer | Feb 13, 2026 | TAX W/H | 217 | $244.55 | $53.1K | Form 4 |
| Wengel Kathryn E | EVP, Chief TO and Risk Officer | Feb 15, 2026 | AWARD | 16,945 | $243.45 | $4.1M | Form 4 |
| Wengel Kathryn E | EVP, Chief TO and Risk Officer | Feb 15, 2026 | OPTION EX. | 635 | — | — | Form 4 |
| Wengel Kathryn E | EVP, Chief TO and Risk Officer | Feb 15, 2026 | AWARD | 1,217 | — | — | Form 4 |
| Wengel Kathryn E | EVP, Chief TO and Risk Officer | Feb 15, 2026 | OPTION EX. | 606 | — | — | Form 4 |
| Wengel Kathryn E | EVP, Chief TO and Risk Officer | Feb 13, 2026 | OPTION EX. | 651 | — | — | Form 4 |
Congress & Senate Trades (152)
Thomas KeanHouse · NJ07Sep 30, 2026
Ro KhannaHouse · CA17Sep 25, 2026
Lloyd DoggettHouse · TX37Sep 8, 2026
Ro KhannaHouse · CA17Sep 4, 2026
Thomas KeanHouse · NJ07Aug 27, 2026
John BoozmanSenate · ARAug 20, 2026
Ro KhannaHouse · CA17Aug 7, 2026
Rich McCormickHouse · GA06Jul 30, 2026
Ro KhannaHouse · CA17Jul 2, 2026
Thomas KeanHouse · NJ07Jun 29, 2026
Lloyd DoggettHouse · TX37Jun 9, 2026
Thomas KeanHouse · NJ07Jun 2, 2026
Ro KhannaHouse · CA17May 1, 2026
Ro KhannaHouse · CA17Apr 13, 2026
Alan ArmstrongSenateMar 30, 2026
Alan ArmstrongSenateMar 27, 2026
Thomas KeanHouse · NJ07Mar 26, 2026
Rich McCormickHouse · GA06Mar 19, 2026
John BoozmanSenate · ARMar 19, 2026
Lloyd DoggettHouse · TX37Mar 10, 2026
Ro KhannaHouse · CA17Mar 6, 2026
Ro KhannaHouse · CA17Mar 6, 2026
Ro KhannaHouse · CA17Jan 29, 2026
Thomas KeanHouse · NJ07Jan 23, 2026
Julie JohnsonHouse · TX32Dec 18, 2025
Lloyd DoggettHouse · TX37Dec 9, 2025
Thomas KeanHouse · NJ07Nov 20, 2025
Julie JohnsonHouse · TX32Nov 13, 2025
Rich McCormickHouse · GA06Nov 5, 2025
Lisa C. McClainHouse · MI09Oct 31, 2025
Lisa C. McClainHouse · MI09Oct 30, 2025
Lisa C. McClainHouse · MI09Oct 30, 2025
Ro KhannaHouse · CA17Oct 30, 2025
Ro KhannaHouse · CA17Oct 30, 2025
Ro KhannaHouse · CA17Oct 30, 2025
Jared MoskowitzHouse · FL23Oct 10, 2025
Ro KhannaHouse · CA17Sep 29, 2025
Val HoyleHouse · OR04Sep 23, 2025
Kelly MorrisonHouse · MN03Aug 19, 2025
Julie JohnsonHouse · TX32Aug 14, 2025
Lisa C. McClainHouse · MI09Aug 4, 2025
Ro KhannaHouse · CA17Aug 4, 2025
Thomas KeanHouse · NJ07Jul 31, 2025
Lisa C. McClainHouse · MI09Jun 24, 2025
Lisa C. McClainHouse · MI09Jun 17, 2025
Scott FranklinHouse · FL18Jun 16, 2025
Pete SessionsHouse · TX17Jun 12, 2025
Lloyd DoggettHouse · TX37Jun 10, 2025
Gilbert CisnerosHouse · CA31May 30, 2025
Jefferson ShreveHouse · IN06May 12, 2025